209 related articles for article (PubMed ID: 28274742)
1. A hyaluronic acid-based hydrogel enabling CD44-mediated chondrocyte binding and gapmer oligonucleotide release for modulation of gene expression in osteoarthritis.
Cai Y; López-Ruiz E; Wengel J; Creemers LB; Howard KA
J Control Release; 2017 May; 253():153-159. PubMed ID: 28274742
[TBL] [Abstract][Full Text] [Related]
2. Fibrin-hyaluronic acid hydrogel-based delivery of antisense oligonucleotides for ADAMTS5 inhibition in co-delivered and resident joint cells in osteoarthritis.
Garcia JP; Stein J; Cai Y; Riemers F; Wexselblatt E; Wengel J; Tryfonidou M; Yayon A; Howard KA; Creemers LB
J Control Release; 2019 Jan; 294():247-258. PubMed ID: 30572032
[TBL] [Abstract][Full Text] [Related]
3. Effect of ligand
Yuan Y; Liu Q; Zhang F; Luo W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 Sept 28; 45(9):1015-1023. PubMed ID: 33051414
[TBL] [Abstract][Full Text] [Related]
4. Enhanced expression of hyaluronic acid in osteoarthritis-affected knee-cartilage chondrocytes during three-dimensional in vitro culture in a hyaluronic-acid-retaining polymer scaffold.
Katoh S; Yoshioka H; Senthilkumar R; Preethy S; Abraham SJK
Knee; 2021 Mar; 29():365-373. PubMed ID: 33690017
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid hydrogels with defined crosslink density for the efficient enrichment of breast cancer stem cells.
Tan S; Yamashita A; Gao SJ; Kurisawa M
Acta Biomater; 2019 Aug; 94():320-329. PubMed ID: 31125725
[TBL] [Abstract][Full Text] [Related]
6. Palmitoylated phosphodiester gapmer designs with albumin binding capacity and maintained in vitro gene silencing activity.
Cai Y; Makarova AM; Wengel J; Howard KA
J Gene Med; 2018 Jul; 20(7-8):e3025. PubMed ID: 29800498
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic Acid (HA), Platelet-Rich Plasm and Extracorporeal Shock Wave Therapy (ESWT) promote human chondrocyte regeneration in vitro and ESWT-mediated increase of CD44 expression enhances their susceptibility to HA treatment.
Vetrano M; Ranieri D; Nanni M; Pavan A; Malisan F; Vulpiani MC; Visco V
PLoS One; 2019; 14(6):e0218740. PubMed ID: 31251756
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of hyaluronic acid/chitosan nanoparticles for the delivery of curcuminoid in knee osteoarthritis and an in vitro evaluation in chondrocytes.
Wang J; Wang X; Cao Y; Huang T; Song DX; Tao HR
Int J Mol Med; 2018 Nov; 42(5):2604-2614. PubMed ID: 30106112
[TBL] [Abstract][Full Text] [Related]
9. High molecular weight hyaluronic acid regulates MMP13 expression in chondrocytes via DUSP10/MKP5.
Furuta J; Ariyoshi W; Okinaga T; Takeuchi J; Mitsugi S; Tominaga K; Nishihara T
J Orthop Res; 2017 Feb; 35(2):331-339. PubMed ID: 27101204
[TBL] [Abstract][Full Text] [Related]
10. Influence of hyaluronic acid modification on CD44 binding towards the design of hydrogel biomaterials.
Kwon MY; Wang C; Galarraga JH; Puré E; Han L; Burdick JA
Biomaterials; 2019 Nov; 222():119451. PubMed ID: 31480001
[TBL] [Abstract][Full Text] [Related]
11. Biodegradable and injectable in situ cross-linking chitosan-hyaluronic acid based hydrogels for postoperative adhesion prevention.
Li L; Wang N; Jin X; Deng R; Nie S; Sun L; Wu Q; Wei Y; Gong C
Biomaterials; 2014 Apr; 35(12):3903-17. PubMed ID: 24507411
[TBL] [Abstract][Full Text] [Related]
12. Konjac glucomannan-based hydrogel with hyaluronic acid as a candidate for a novel scaffold for chondrocyte culture.
Kondo T; Shinozaki T; Oku H; Takigami S; Takagishi K
J Tissue Eng Regen Med; 2009 Jul; 3(5):361-7. PubMed ID: 19399729
[TBL] [Abstract][Full Text] [Related]
13. Ribonuclease H1-dependent hepatotoxicity caused by locked nucleic acid-modified gapmer antisense oligonucleotides.
Kasuya T; Hori S; Watanabe A; Nakajima M; Gahara Y; Rokushima M; Yanagimoto T; Kugimiya A
Sci Rep; 2016 Jul; 6():30377. PubMed ID: 27461380
[TBL] [Abstract][Full Text] [Related]
14. Mucin-mediated nanocarrier disassembly for triggered uptake of oligonucleotides as a delivery strategy for the potential treatment of mucosal tumours.
Martirosyan A; Olesen MJ; Fenton RA; Kjems J; Howard KA
Nanoscale; 2016 Jul; 8(25):12599-607. PubMed ID: 26694897
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic Acid Modified Curcumin-Loaded Chitosan Nanoparticles Inhibit Chondrocyte Apoptosis to Attenuate Osteoarthritis via Upregulation of Activator Protein 1 and RUNX Family Transcription Factor 2.
Wang J; Zhang L; Zhu J; Gu J; Wang X; Tao H
J Biomed Nanotechnol; 2022 Jan; 18(1):144-157. PubMed ID: 35180907
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled hyaluronic acid nanoparticles for osteoarthritis treatment.
Kang LJ; Yoon J; Rho JG; Han HS; Lee S; Oh YS; Kim H; Kim E; Kim SJ; Lim YT; Park JH; Song WK; Yang S; Kim W
Biomaterials; 2021 Aug; 275():120967. PubMed ID: 34153786
[TBL] [Abstract][Full Text] [Related]
17. CD44 targeted delivery of siRNA by using HA-decorated nanotechnologies for KRAS silencing in cancer treatment.
Tirella A; Kloc-Muniak K; Good L; Ridden J; Ashford M; Puri S; Tirelli N
Int J Pharm; 2019 Apr; 561():114-123. PubMed ID: 30822503
[TBL] [Abstract][Full Text] [Related]
18. Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) invovement.
Lisignoli G; Grassi F; Zini N; Toneguzzi S; Piacentini A; Guidolin D; Bevilacqua C; Facchini A
Arthritis Rheum; 2001 Aug; 44(8):1800-7. PubMed ID: 11508432
[TBL] [Abstract][Full Text] [Related]
19. The effect of hyaluronan on CD44-mediated survival of normal and hydroxyl radical-damaged chondrocytes.
Brun P; Panfilo S; Daga Gordini D; Cortivo R; Abatangelo G
Osteoarthritis Cartilage; 2003 Mar; 11(3):208-16. PubMed ID: 12623292
[TBL] [Abstract][Full Text] [Related]
20. Novel nano-microspheres containing chitosan, hyaluronic acid, and chondroitin sulfate deliver growth and differentiation factor-5 plasmid for osteoarthritis gene therapy.
Chen Z; Deng S; Yuan DC; Liu K; Xiang XC; Cheng L; Xiao DQ; Deng L; Feng G
J Zhejiang Univ Sci B; 2018 Dec.; 19(12):910-923. PubMed ID: 30507075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
